In-vitro fertilization is a type of assisted reproductive
technology that helps women in conceiving. The global IVF market was valued at
$9.3 billion in 2012 and is expected to grow up to $21.6 billion by 2020.
Delayed pregnancy in women is one of the major driving factors of the IVF
market, as the chances of conceiving lowers with age. The pregnancy success
rate with IVF technique is higher in the age group of 35-39. Other driving
factors of the IVF market are rise in infertility rate due to rise in stress
levels, change in life style and fertility related diseases. Globally, the
number of couples with infertility issues was found to be 48.5 million in 2010.
The major limiting factor of this market is the cost
involved in the treatment. The patient may not conceive in the first cycle of
IVF procedure. Many cycles have to be undergone by the patient to achieve
pregnancy, and this adds to the overall cost. The average cost of this
procedure is approximately $10,000-$20,000. This acts as a major limitation in
adoption of the technique for people with low income. Another challenge is the
low level of awareness in the developing economies such as Nigeria. Awareness
can be created through medical tourism and availability of low cost IVF
treatments.
The companies profiled in this report include Vitrolife AB,
Cooper Surgical. Inc., Cook Medicals, Thermo Scientific, Irvine Scientific
Inc., Genea Biomedx, Oxford Gene Technology, Auxogyn Inc., EMD Serono Inc. and
Ova Science.
KEY BENEFITS
In-depth analysis of the IVF market, segmented based on instruments, reagents and media, technology, end users and geographies
Quantitative analysis of the current market and estimations through 2013-2020
Assessment and ranking of the factors affecting the global market and impact analysis of the same
Identification of key investment pockets in the market, which would assist companies to take profitable investment decisions
Study of the bargaining power of buyers and suppliers in the market, based on porters five force analysis
Understanding the key intermediaries in the market based on value chain analysis
Analysis of trends in various geographic segments that would help the companies to plan their strategies depending on the region
SWOT and competitive analysis of the key players, which would help stakeholders to understand trends followed by their competitors and take actionable decisions
KEY BENEFITS
In-depth analysis of the IVF market, segmented based on instruments, reagents and media, technology, end users and geographies
Quantitative analysis of the current market and estimations through 2013-2020
Assessment and ranking of the factors affecting the global market and impact analysis of the same
Identification of key investment pockets in the market, which would assist companies to take profitable investment decisions
Study of the bargaining power of buyers and suppliers in the market, based on porters five force analysis
Understanding the key intermediaries in the market based on value chain analysis
Analysis of trends in various geographic segments that would help the companies to plan their strategies depending on the region
SWOT and competitive analysis of the key players, which would help stakeholders to understand trends followed by their competitors and take actionable decisions
KEY AUDIENCES
Hospitals
Fertility clinics
Instruments and reagent manufacturers
Cryopreservation banks
Government and private institutes
Hospitals
Fertility clinics
Instruments and reagent manufacturers
Cryopreservation banks
Government and private institutes
No comments:
Post a Comment